Growth Metrics

Arrowhead Pharmaceuticals (ARWR) Short-Term Debt repayments (2025)

Arrowhead Pharmaceuticals (ARWR) has disclosed Short-Term Debt repayments for 1 consecutive years, with $50.0 million as the latest value for Q2 2025.